Digital Biomarkers: Impact on future clinical development and outcomes
How digital biomarkers could transform clinical research
It is proven that digital biomarkers can accelerate and increase the efficiency of clinical drug development. Yet despite progress, the acceptance and adoption of digital biomarkers remains limited. What are the verification, analytical and clinical validation processes and technologies needed to develop the digital tools that can drive superior clinical research and patient care outcomes? In this report experts explore the opportunities and challenges facing this innovative area of clinical research.
Companies
Roche, Merck & Co., Genentech, SysNav, Activinsights, Bellerophon Therapeutics
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- The parameters for creating and applying digital biomarkers in clinical trials
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- The opportunity for biopharma to utilise digital health technologies to create and apply digital biomarkers in clinical trials
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Challenges raised by the use of digital biomarkers in clinical trials
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- What does the future hold?
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Further reading
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook